NCT03682042

Brief Summary

An extension of the CORDMILK trial, the CORDMILK follow-up trial will evaluate the neurodevelopmental outcomes at 22-26 months age of term/late preterm infants who were non-vigorous at birth and received umbilical cord milking (UCM) or early cord clamping (ECC).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,442

participants targeted

Target at P75+ for not_applicable

Timeline
18mo left

Started Oct 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

9 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Oct 2022Oct 2027

First Submitted

Initial submission to the registry

September 20, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 24, 2018

Completed
4.1 years until next milestone

Study Start

First participant enrolled

October 17, 2022

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2027

Last Updated

July 10, 2025

Status Verified

July 1, 2025

Enrollment Period

4.9 years

First QC Date

September 20, 2018

Last Update Submit

July 7, 2025

Conditions

Keywords

Placental transfusion

Outcome Measures

Primary Outcomes (1)

  • Neurodevelopmental Outcome at 2 Years of Age

    Neurodevelopmental assessment will be performed by the trained and experienced examiner who will be blinded to the interventions. Severe neurodevelopmental impairment will be defined having at least one of the following: BSID (IV) composite cognitive score \<70, GMFCS level 3-5, blindness (vision \<20/200), or hearing impairment requiring hearing aids/cochlear implant. Moderate neurodevelopmental impairment will be defined as having a cognitive composite score 70-84, GMFCS level 2, unilateral blindness (vision/20/200 in only one eye), or hearing impairment with no amplification/cochlear implant.

    22-26 months

Secondary Outcomes (1)

  • Neurodevelopmental Outcome at 1 Year of Age

    10-14 months

Study Arms (2)

Umbilical Cord Milking

ACTIVE COMPARATOR

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 10-15 seconds.

Other: Umbilical Cord Milking

Early Cord Clamping

NO INTERVENTION

The umbilical cord is clamped immediately after the delivery (within 60 seconds).

Interventions

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 10-15 seconds.

Umbilical Cord Milking

Eligibility Criteria

Age22 Months - 26 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Enrolled in CORDMILK trial
  • Non-vigorous at birth

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

KLE Academy of Higher Education and Research (Deemed-to-be-University) Jawaharlal Nehru Medical College

Belagavi, Karnataka, 590010, India

NOT YET RECRUITING

Indira Gandhi Government Medical College & Hospital

Nagpur, Maharashtra, 440018, India

RECRUITING

Pimpri Chinchwad Municipal Corporation's Post-Graduate Institute, Yashwantrao Chavan Memorial Hospital

Pune, Maharashtra, 411018, India

RECRUITING

Government Medical College

Chandrapur, MS, 442401, India

RECRUITING

Daga Memorial Woman and Children Hospital

Nagpur, MS, 440002, India

RECRUITING

Government Medical College and Hospital

Nagpur, MS, 440009, India

RECRUITING

All India Institute of Medical Science

Nagpur, MS, 441108, India

NOT YET RECRUITING

Mahatma Gandhi Institute of Medical Sciences/ Kasturba Hospital

Wardha, MS, 442102, India

RECRUITING

Sawai Man Singh (SMS) Medical College

Jaipur, Rajasthan, 302004, India

RECRUITING

Related Publications (1)

  • Yogeshkumar S, Vernekar SS, Dhaded SM, Talekar K, Leiby BE, Hartman R, Vaucher Y, Chouthai N, Girish M, Jain M, Jain S, Parvekar S, Jain V, Patankar A, Suryawanshi M, Tiwari M, Waikar M, Nashine N, Ambike D, Asalkar M, Kulkarni R, Haribhaktha S, Narkhede H, Chaudhari S, Kamble M, Shrirame D, Falke B, Mehta S, Verma A, Gothwal S, Goudar SS, Derman R, Katheria A, Aghai ZH. CORDMILK: Umbilical Cord Milking versus Early Cord Clamping on short-and long-term outcomes in neonates who are non-vigorous at birth-study protocol of a multi-center, cluster-randomized, crossover-controlled trial. Trials. 2025 Nov 17;26(1):509. doi: 10.1186/s13063-025-09197-8.

MeSH Terms

Conditions

Hypoxia-Ischemia, BrainAsphyxia NeonatorumFetofetal Transfusion

Interventions

Umbilical Cord Clamping

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAnemia, NeonatalAnemiaHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Delivery, ObstetricObstetric Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Zubair Aghai, MD

    Nemours Children's Clinic

    PRINCIPAL INVESTIGATOR
  • Anup Katheria, MD

    Sharp Mary Birch Hospital for Women & Newborns

    PRINCIPAL INVESTIGATOR
  • Sangappa Dhaded

    KLE Academy of Higher Education and Research

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zubair H Aghai, MD

CONTACT

Anup Katheria, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Neurodevelopmental providers will be blinded to the randomization of the toddler during the examination.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Neurodevelopmental assessments will be done at 2 years of age (22-26 months) for subjects who were randomized to receive either early cord clamping or umbilical cord milking as part of the CORDMILK trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

September 20, 2018

First Posted

September 24, 2018

Study Start

October 17, 2022

Primary Completion (Estimated)

August 30, 2027

Study Completion (Estimated)

October 30, 2027

Last Updated

July 10, 2025

Record last verified: 2025-07

Locations